Nuacht
US biotech PTC Therapeutics released mixed new data on its Phase II trial of PCT187 (votoplam) in Huntington’s disease. UK ...
Poxel is a biopharmaceutical company developing drugs for metabolic diseases, with a focus on type 2 diabetes. Based in Lyon, France, Poxel was spun out in 2009 from Merck Serono. Poxel is focsed on ...
A clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic ...
US biotech IGM Biosciences (Nasdaq: IGMS), which is developing and delivering medicines to treat patients with autoimmune and ...
US precision oncology company Boundless Bio (Nasdaq: BOLD) has announced financial results and business highlights for the ...
A fully integrated global biopharma company headquartered in Lugano, Switzerland. It is focused on improving the lives of cancer patients all over the world with a leading position in cancer ...
DanDrit Biotech is focused on the clinical development of a dendritic cell vaccine for treatment of colorectal cancer. The company, which is co-located in the USA and Denmark, was founded in 2001, ...
Amneal is a generics manufacturer headquartered in Bridgewater, New Jersey. Amneal (NYSE: AMRX) is a generics manufacturer headquartered in Bridgewater, New Jersey. The company was formed in May 2018 ...
A Feature on M&A, VC investment, licensing and partnerships in the radiopharmaceuticals arena.
Oculis Holding (Nasdaq: OCS) reported a net loss of $36 million for the first quarter of 2025, more than double the loss in ...
The UK government has announced a trade agreement with the USA. The UK-US Economic Prosperity Deal was agreed on Thursday May ...
The human immunodeficiency virus (HIV) market across the seven major markets (7MM: the USA, France, Germany, Italy, Spain, ...
Cuireadh roinnt torthaí i bhfolach toisc go bhféadfadh siad a bheith dorochtana duit
Taispeáin torthaí dorochtana